THIS NEW PROSPECT FOR WEIGHT MANAGEMENT ?

Scientists are excitedly focused on retatrutide, a novel drug from Eli Lilly, as a possible breakthrough in weight reduction . Unlike many earlier approaches, retatrutide is a dual -action agonist targeting both GLP-1 and GIP, chemicals that impact appetite and blood sugar control . Preliminary